➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Baxter
Boehringer Ingelheim
Harvard Business School
McKinsey
AstraZeneca
Express Scripts

Last Updated: September 26, 2020

DrugPatentWatch Database Preview

NICARDIPINE HYDROCHLORIDE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Nicardipine Hydrochloride, and when can generic versions of Nicardipine Hydrochloride launch?

Nicardipine Hydrochloride is a drug marketed by Ani Pharms Inc, Epic Pharma, Mylan, Am Regent, Exela Pharma Science, Mylan Institutional, Navinta Llc, Sun Pharma Global, West-ward Pharms Int, and Wockhardt. and is included in twelve NDAs.

The generic ingredient in NICARDIPINE HYDROCHLORIDE is nicardipine hydrochloride. There are eleven drug master file entries for this compound. Nine suppliers are listed for this compound. Additional details are available on the nicardipine hydrochloride profile page.

US ANDA Litigation and Generic Entry Outlook for Nicardipine Hydrochloride

A generic version of NICARDIPINE HYDROCHLORIDE was approved as nicardipine hydrochloride by MYLAN on July 18th, 1996.

  Start Trial

Drug patent expirations by year for NICARDIPINE HYDROCHLORIDE
Recent Clinical Trials for NICARDIPINE HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Damietta UniversityPhase 2
Kafrelsheikh UniversityPhase 2
Kafrelsheikh UniversityPhase 3

See all NICARDIPINE HYDROCHLORIDE clinical trials

Medical Subject Heading (MeSH) Categories for NICARDIPINE HYDROCHLORIDE

US Patents and Regulatory Information for NICARDIPINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ani Pharms Inc NICARDIPINE HYDROCHLORIDE nicardipine hydrochloride CAPSULE;ORAL 074439-001 Dec 10, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
Exela Pharma Science NICARDIPINE HYDROCHLORIDE IN 0.9% SODIUM CHLORIDE nicardipine hydrochloride INJECTABLE;INTRAVENOUS 022276-002 Apr 7, 2016 RX No No   Start Trial   Start Trial   Start Trial
Epic Pharma NICARDIPINE HYDROCHLORIDE nicardipine hydrochloride CAPSULE;ORAL 074928-001 Mar 19, 1998 AB RX No No   Start Trial   Start Trial   Start Trial
Ani Pharms Inc NICARDIPINE HYDROCHLORIDE nicardipine hydrochloride CAPSULE;ORAL 074439-002 Dec 10, 1996 DISCN No No   Start Trial   Start Trial   Start Trial
Exela Pharma Science NICARDIPINE HYDROCHLORIDE nicardipine hydrochloride INJECTABLE;INJECTION 022276-001 Jul 24, 2008 RX No No   Start Trial   Start Trial   Start Trial
Epic Pharma NICARDIPINE HYDROCHLORIDE nicardipine hydrochloride CAPSULE;ORAL 074928-002 Mar 19, 1998 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Baxter
Mallinckrodt
Johnson and Johnson
Medtronic
McKinsey

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.